Hangzhou Adcoris Biopharmacy Co., Ltd
2 clinical trials · Sponsor
◉ Watch Hangzhou Adcoris Biopharmacy Co., Ltd
| Record | Firm | Date |
|---|---|---|
| An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors (NCT06238401) | Hangzhou Adcoris Biopharmacy Co., Ltd | 2024-10-29 |
| Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors (NCT05423977) | Hangzhou Adcoris Biopharmacy Co., Ltd | 2021-12-17 |
Track Hangzhou Adcoris Biopharmacy Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.